Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Elixiron Immunotherapeutics (Cayman) Limited (7871) Stock Price & Analysis

7871 Stock Chart & Stats

117.50-6.00(-4.86%)
At close:
$100$150Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
$105.00 - $122.00
52-Week Range
$37.55 - $185.00
Previous Close
$123.50
Volume
N/A
Average Volume (3M)
634.07K
Market Cap
TWD 15.78B
Enterprise Value
N/A
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
―
Beta
0.80
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

7871 FAQ

What was Elixiron Immunotherapeutics (Cayman) Limited’s price range in the past 12 months?
Elixiron Immunotherapeutics (Cayman) Limited lowest stock price was TWD 37.55 and its highest was TWD 185.00 in the past 12 months.
What is Elixiron Immunotherapeutics (Cayman) Limited’s market cap?
Elixiron Immunotherapeutics (Cayman) Limited’s market cap is TWD 15.78B.
When is Elixiron Immunotherapeutics (Cayman) Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Elixiron Immunotherapeutics (Cayman) Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Elixiron Immunotherapeutics (Cayman) Limited pay dividends?
Elixiron Immunotherapeutics (Cayman) Limited does not currently pay dividends.
What is Elixiron Immunotherapeutics (Cayman) Limited’s EPS estimate?
Elixiron Immunotherapeutics (Cayman) Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Elixiron Immunotherapeutics (Cayman) Limited have?
Elixiron Immunotherapeutics (Cayman) Limited has 134,278,200 shares outstanding.
Which hedge fund is a major shareholder of Elixiron Immunotherapeutics (Cayman) Limited?
Currently, no hedge funds are holding shares in TW:7871
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology